A randomised study about the effect on survival of hormonal therapy versus hormonal therapy plus local external radiation therapy in patients with primary diagnosed metastasised (M+) prostate cancer.
Completed
- Conditions
- Prostate cancer
- Registration Number
- NL-OMON29395
- Lead Sponsor
- Onze Lieve Vrouwe Gasthuis, afdeling urologie, Amsterdam. Erasmus Medisch Centrum, afdeling urologie Rotterdam (P.C.M.S. Verhagen)
- Brief Summary
/A
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Completed
- Sex
- Not specified
- Target Recruitment
- 446
Inclusion Criteria
1. Histologically proven adenocarcinoma of the prostate;
2. Stage T1-4, G1-3, N0-2, M1;
Exclusion Criteria
1. Start therapy more than 8 weeks after the initial diagnoses;
2. Other treatment for prostate cancer before start of the studytherapy;
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Survival.
- Secondary Outcome Measures
Name Time Method 1. Biochemical progression;<br /><br>2. Health related quality of life.